VBI Vaccines Announces PreHevbri® is Now Available in the Netherlands and Belgium for the Prevention of Hepatitis B in Adults
VBI Vaccines Inc. (Nasdaq: VBIV) has announced the availability of PreHevbri® [Hepatitis B vaccine (recombinant, adsorbed)] in the Netherlands and Belgium for active immunization against all known subtypes of the hepatitis B virus (HBV) in adults. The vaccine will be launched in partnership with Valneva, their marketing and distribution partner. PreHevbri® is currently the only approved 3-antige..